Repeat administration of high dose melphalan in relapsed myeloma
Open Access
- 1 November 1993
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 68 (5), 983-987
- https://doi.org/10.1038/bjc.1993.466
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Allogeneic Bone Marrow Transplantation in Multiple MyelomaNew England Journal of Medicine, 1991
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- High‐dose chemotherapy and autologous bone marrow transplantation for myelomaEuropean Journal of Haematology, 1989
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- INCREASE IN CLONOGENIC TUMOUR CELLS IN BONE MARROW OF PATIENTS WITH MULTIPLE MYELOMA TREATED WITH VINCRISTINE, DOXORUBICIN, AND METHYLPREDNISOLONEThe Lancet, 1988
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Chemotherapy of previously untreated multiple myeloma patients: an analysis of recent treatment results.1986
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- The Current Status and Future Prospects of Treatment for Multiple MyelomaClinics in Haematology, 1982
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977